An Open-Label, Multicenter, Phase I, Dose Escalation Study with Phase II Expansion Cohort to Determine the Safety, Pharmacokinetics, and Preliminary Antitumor Activity of Intravenous TKM-080301 in Subjects with Advanced Hepatocellular Carcinoma

Imane El Dika, Ho Yeong Lim, Wei Peng Yong, Chia Chi Lin, Jung Hwan Yoon, Manuel Modiano, Bradley Freilich, Hye Jin Choi, Tsu Yi Chao, Robin K. Kelley, Joanne Brown, Jennifer Knox, Baek Yeol Ryoo, Thomas Yau, Ghassan K. Abou-Alfa

Research output: Contribution to journalArticle

11 Citations (Scopus)

Fingerprint Dive into the research topics of 'An Open-Label, Multicenter, Phase I, Dose Escalation Study with Phase II Expansion Cohort to Determine the Safety, Pharmacokinetics, and Preliminary Antitumor Activity of Intravenous TKM-080301 in Subjects with Advanced Hepatocellular Carcinoma'. Together they form a unique fingerprint.

Medicine & Life Sciences